Subject to approval from its shareholders, the company will distribute total dividends worth RON20 million from last year’s profits.
In 2011, Zentiva, a unit of French drug maker Sanofi-Aventis, paid a gross dividend of RON0.0812 a share.
The company reported a net profit of RON32.18 million in 2012, down 5% on the year. Sales rose 5.3% to RON248 million.
Zentiva is 74.9% owned by Sanofi-Aventis.
Wednesday, Zentiva’s shares closed down 1.15% at RON0.82 in Bucharest. (EUR1=RON4.4179)